Tirzepatide

‍

Vial | Amount: 15mg / 30mg | Price: €79.90 / €129.90

‍

Overview:

Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it targets two separate metabolic signalling pathways simultaneously. 

This dual-action profile has made it one of the most-studied compounds in current metabolic research, offering a controlled model for investigating how combined incretin receptor activation influences glucose homeostasis and energy regulation at a cellular level.

‍

Research Applications:

• Studying how simultaneous activation of GIP and GLP-1 receptors influences downstream metabolic signalling
• Investigating glycaemic regulation and insulin secretion response mechanisms in vitro
• Modelling the relationship between incretin hormones and cellular energy balance pathways
• Comparative research into single versus dual incretin receptor agonism in metabolic studies

‍

Commonly Paired With:

Frequently studied alongside MOTS-c in protocols examining combined metabolic and mitochondrial energy pathway research. Bacteriostatic Water required for reconstitution, available separately. Do not shake during reconstitution.

‍

Storage & Handling:

Store lyophilised peptide at -20°C. Once reconstituted, store at 2°C–8°C and use within 28 days. Handle in a sterile environment. Avoid repeated freeze-thaw cycles.

‍

Regulatory Notice:

For Research Use Only. Not for human or animal administration. Not a medicinal product. All handling must be performed by qualified personnel in a controlled laboratory setting.

‍

‍